Promatix offers services ranging from design to installation and specializes in developing cancer therapies using bispecific antibodies. The company engages in biopharmaceutical research, antibody engineering, clinical trial support, and therapeutic development. Additional services include molecular diagnostics, customized assay development, and bioinformatics analysis, supporting innovation in oncology and personalized medicine.
